The dark skin pigment melanin protects us from the sun’s damaging rays by absorbing light energy and converting it to heat. This could make it a very effective tool in tumor diagnosis and treatment, as demonstrated by a team from the Technical University of Munich (TUM) and Helmholtz Zentrum München. The scientists managed to create melanin-loaded cell membrane derived nanoparticles, which improved tumor imaging in an animal model while also slowing the growth of the tumor.
Nanoparticles are considered a promising weapon in the fight against tumors due to the fact that tumor tissue absorbs them more readily than healthy cells because their vascular system is more permeable. A good example is provided by outer membrane vesicles (OMVs), which are basically small bubbles surrounded by bacterial membrane. These 20- to 200-nanometer particles are of interest because they are biocompatible, biodegradable and can be easily and inexpensively produced in bacteria, even in large volumes. Once loaded with medicinal active agents, they are easy to administer.
NANOPARTICLES CARRYING A BLACK CARGO
The huge potential of OMVs in tumor diagnosis and treatment has been demonstrated by Prof. Vasilis Ntziachristos, Professor of Biological Imaging at TUM, and his team. Their work builds on the characteristic properties of OMVs and melanin.’
Dr. Vipul Gujrati, first author of the study, explains the principle: “Melanin absorbs light very readily – even in the infrared spectrum. We use precisely this light in our optoacoustic imaging technique for tumor diagnosis. It simultaneously converts this absorbed energy into heat, which is then emitted. Heat is also a way to combat tumors – other researchers are currently exploring this method in clinical trials.”
Optoacoustics, a method which has been significantly advanced by Ntziachristos, combines the benefits of optical imaging and ultrasound technology. Weak laser pulses gently heat the tissue, causing it to briefly expand very slightly. Ultrasound signals are produced when the tissue contracts again as it cools down. The measured signals vary depending on the tissue type. The scientists record them with special detectors and “translate” them into three-dimensional images. Sensor molecules or probes (such as OMVs) can improve the specificity and accuracy of the technique even further.
HEAT BUILD-UP REDUCES TUMOR GROWTH
The scientists initially had to overcome a problem specific to melanin: It is not very water-soluble and therefore difficult to administer. This is where the OMVs came into play. The researchers engineered bacteria in such a way that they produce melanin and store it in their membrane derived nanoparticles. They then tested the black nanoparticles in mice which had tumors in their lower back region. The particles were injected directly into the tumor, which was excited with infrared laser pulses as part of the optoacoustic procedure.
OMVs proved to be suitable sensor probes for this diagnosis technique because they delivered sharp, high-contrast images of the tumor. They are also well-suited to photothermal therapy approaches, where the tumor tissue is heated with stronger laser pulses in order to kill the cancer cells. The melanin in the nanoparticles caused the temperature of the tumor tissue to rise from 37 °C to up to 56 °C. Control tumors with no melanin only reached a maximum temperature of 39 °C. In the ten days following the treatment, the tumors grew at a significantly slower rate than those in the control group that had not received melanin OMVs. This heat effect was amplified by another positive effect of the particles: By causing a slight non-specific inflammation in the tumor tissue, the immune system was triggered to attack the tumor.
“Our melanin nanoparticles fit into the new medical field of theranostics – where therapy and diagnostics are combined. This makes them a highly interesting option for use in clinical practice,” says Ntziachristos. The scientists will now develop their OMVs further to bring them into clinical use in the future.
Learn more: Black nanoparticles slow the growth of tumors
The Latest on: Theranostics
via Google News
The Latest on: Theranostics
- Gold Nanoprobes for Theranosticson June 19, 2020 at 5:00 pm
Nanotechnology can be used in theranostics through contrast agents for imaging, immunotargeted therapy, efficient drug delivery and detection. Gold nanoprobes (GNPs) are nanovectors of different ...
- 10-Q: INTERNATIONAL STEM CELL CORPon June 19, 2020 at 10:47 am
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion of our ...
- Theranostics Meets Traditional Chinese Medicineon June 18, 2020 at 5:00 pm
not to mention applying theranostics to this area to attempt to avoid potential clinical risk. Table 2. Effect of genetic polymorphisms on herb–drug interactions. Herbs Drugs Effect of genetic ...
- BIO Integration (BIOI) Virtual Conference Series 2020on June 17, 2020 at 9:23 am
Virtual Conference Series 2020 We are pleased to announce details of the BIO Integration (BIOI) virtual conference series 2020. Online webinars supported by live question and answer sessions will be ...
- Using nanotheranostics approach to treat canceron June 10, 2020 at 7:30 pm
The concept of theranostics revolves around the stratification of patients into specific groups based on their response to different treatments and their disease risks.
- What caught Mike Milken's eye in Melbourneon June 10, 2020 at 7:04 am
This work holds the key to eliminating prostate cancer as a cause of death,' says the American philanthropist.
- Melbourne specialists deliver ‘stunning’ prostate cancer breakthroughon June 10, 2020 at 4:00 am
A breakthrough treatment for prostate cancer by Melbourne specialists has delivered “stunning” results. A world-leading centre to accelerate research and development of the theranostic treatment, ...
- With faster cell modeling towards the vaccine and cure for COVID-19on June 4, 2020 at 8:56 am
Sacco ", University of Milan have recently published an article in the scientific journal Theranostics, which will help the international scientific community to understand the mechanisms of SARS ...
- The Theranostics Promiseon May 28, 2020 at 5:00 pm
Theranostics will drive meaningful adoption.” Another key question is which clinical laboratories can perform the test. Buxton says there are more than 6,000 clinical labs in the United States ...
- Pharmacogenomics Technology Market Analysis – New Opportunities Explored, Expansion at High CAGR Anticipated by 2025 | Million Insightson March 23, 2020 at 3:10 am
According to new report available with Million Insights, the global pharmacogenomics theranostics & companion diagnostics (CDx) industry report on is foretold to provide a robust support for ...
via Bing News